Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00023023 · ClinicalTrials.gov registry record
Study of Transfusion-Transmitted Infections
A clinical trial of Blood Donation and Viral Disease, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 1,771
- Enrollment target
- 3
- Study locations
NCT00023023 is a study of Blood Donation and Viral Disease that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 1,771 participants. The trial reports 3 study locations across 2 states.
The verdict
NCT00023023, a study of Blood Donation and Viral Disease, has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 1,771 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will follow blood transfusion recipients for 6 to 9 months following transfusion to monitor the quality and safety of blood transfusion. Improved viral testing and careful donor screening in the last several years has dramatically reduced the rates of transfusion-related HIV and hepatitis. Nevertheless, ongoing surveillance of transfusion-related infections is essential to maintain a high safety standard and to determine the transfusion risk of other infectious agents, such as cytomegalovirus, Epstein-Barr virus, parvovirus B-19, HHV-8 (Kaposi s sarcoma virus) and other possible hepatitis viruses that might be blood-transmitted. Transfused patients blood will be tested for various infectious agents. Their blood samples and blood samples from their donors will be frozen and stored in a repository so that any new infectious agent can be rapidly evaluated for its danger to the safety of the blood supply. Adult patients at the National Institutes of Health and children at the Children s National Medical Center who are scheduled to receive a blood transfusion or to undergo surgery for which a blood transfusion may be needed are eligible for this study. All participants will have a 20- to 25-milliliter (about 2 tablespoonfuls) blood sample drawn before their transfusion and again at 1, 2, 4, 12 and 24 weeks after the transfusion. Patients who are transfused on more than one occasion over the course of the study will provide three additional monthly samples. Patients who develop a transfusion-transmitted infection during the study will provide up to four more samples to study the infection and its effects. Participants will complete a brief questionnaire at the end of the study regarding prior blood transfusions and the development of any illnesses, such as hepatitis, that might have been caused by the transfusion. ...
Conditions Studied
Study Locations (3)
Maryland
- NIH Heart Center at Suburban Hospital Johns Hopkins Medicine - Bethesda
- National Institutes of Health Clinical Center - Bethesda
District of Columbia
- Childrens National Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,771 participants |
| Start Date | 2002-01-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00023023
The ClinicalTrials.gov registry entry for NCT00023023 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,771 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Blood Donation appearing as the primary indexed condition, and to 0 interventions.
NCT00023023 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Maryland, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT00023023 about?
NCT00023023 is a clinical study titled "Study of Transfusion-Transmitted Infections". This study will follow blood transfusion recipients for 6 to 9 months following transfusion to monitor the quality and safety of blood transfusion. Improved viral testing and careful donor screening in the last several years has dramatically reduced the rates of transfusion-related HIV and hepatitis...
What is the current status of trial NCT00023023?
This trial is currently completed. The enrollment target is 1,771 participants. The study started on 2002-01-17.
What conditions does trial NCT00023023 study?
This clinical trial studies the following conditions: Blood Donation, Viral Disease, Transfusion-Transmitted Infections.
Who is sponsoring clinical trial NCT00023023?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00023023 being conducted?
This trial has 3 study locations across District of Columbia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Donation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.